# IntelliPharmaCeutics Corp. – FDA Inspection, Jun 14, 2019

Source: https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/c33b77c0-b3fa-45f7-ae87-48a3ec032d64
Source feed: FDA_Inspections

> FDA inspection 1095607 of IntelliPharmaCeutics Corp., June 14, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095607
- Company Name: IntelliPharmaCeutics Corp.
- Inspection Date: 2019-06-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1190656 - 2022-09-26
- FDA Inspection 1027099 - 2017-07-14
- FDA Inspection 885403 - 2014-05-24
- FDA Inspection 737274 - 2011-07-23
- [FDA Inspection 698518 - 2010-11-18](https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/d291354e-811b-499e-be41-64f468bb866b)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/qin-xu/176a88a7-a11e-4374-a64a-378806e76d84)

Company: https://www.keypedia.com/companies/intellipharmaceutics-corp/78f18be2-f4f4-44f4-88d7-30d9f8f36ac5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
